Exome Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-12-2024
- Paid Up Capital ₹ 2.80 M
as on 16-12-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.27 Cr
as on 16-12-2024
- Satisfied Charges ₹ 3.52 Cr
as on 16-12-2024
- Revenue 85.97%
(FY 2021)
- Profit -16.86%
(FY 2021)
- Ebitda -11.51%
(FY 2021)
- Net Worth 35.37%
(FY 2021)
- Total Assets 24.31%
(FY 2021)
About Exome Life Sciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.80 M.
The company currently has active open charges totaling ₹25.27 Cr. The company has closed loans amounting to ₹3.52 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sreemannarayana Pasumarthi, Pavan Velpuri, Suresh Ramaswamy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304TG2017PTC116405
- Company No.
116405
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Exome Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Ramaswamy  | Managing Director | 24-Nov-2018 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreemannarayana Pasumarthi | Whole-Time Director | 07-Apr-2017 | Current |
| Pavan Velpuri | Director | 07-Apr-2017 | Current |
| Honey Lahoti | Whole-Time Director | 11-May-2020 | Current |
Financial Performance and Corporate Structure Insights of Exome Life Sciences.
Exome Life Sciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 85.97% increase. The company also saw a substantial fall in profitability, with a 16.86% decrease in profit. The company's net worth Soared by an impressive increase of 35.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Exome Life Sciences?
In 2021, Exome Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kph Infotech Private LimitedActive 4 years 2 monthsSreemannarayana Pasumarthi, Pavan Velpuri and 1 more are mutual person
Intron Life Sciences Private LimitedActive 6 years 2 monthsSreemannarayana Pasumarthi and Pavan Velpuri are mutual person
Biome Biologicals Private LimitedActive 3 years 10 monthsSreemannarayana Pasumarthi and Pavan Velpuri are mutual person
Purplecow Foods Private LimitedActive 9 years 3 monthsSreemannarayana Pasumarthi and Pavan Velpuri are mutual person
- Magma & Flowra Skin Care Private LimitedActive 11 months 23 days
Sreemannarayana Pasumarthi and Honey Lahoti are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Sep 2024 | ₹1.80 Cr | Open |
Axis Bank Limited Creation Date: 30 Sep 2024 | ₹6.48 M | Open |
Axis Bank Limited Creation Date: 30 Sep 2024 | ₹1.64 Cr | Open |
How Many Employees Work at Exome Life Sciences?
Exome Life Sciences has a workforce of 56 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Exome Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exome Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
